23 May 2023>: Original Paper
Safety and Efficacy of 4 mg·kg Sugammadex for Simultaneous Pancreas-Kidney Transplantation Recipients: A Prospective Randomized TrialJiancheng Tang 12ABCDEFG , Rongzhi He 2ABCEF , Lei Zhang 3ABD , Shiyuan Xu 1ABCDEFG*
Ann Transplant 2023; 28:e940211
Figure 4 (A) Time of recovery to TOF=0.7/0.9 for both groups. (B) Extubation time and length of PACU stay in both groups. Scr and AMS at T2–6 were significantly lower than that at T0–1 (P<0.01), CCr at T2–6 was significantly higher than that at T0–1 (P<0.01). There was no significantly significant difference in the concentration of Scr, CCr, and AMS between the 2 groups at the same timepoint (P>0.05). MAP, HR, and Glu at T1 in group S were higher compared with group N (P<0.05). MAP – mean arterial pressure; HR – heart rate; Scr – serum creatinine; CCr – creatinine clearance rate; AMS – serum amylase, Glu – blood glucose; S – sugammadex; N – neostigmine. T0, the start of surgery; 8 hours (T1), 12 hours (T2), 36 hours (T3), 60 hours (T4), 84 hours (T5), and 108 hours (T6) after the surgery completed. (This figure was made using Microsoft® Excel® 2019MSO (2303 Build 16.0.16227.20202) 64, Microsoft Corporation).